Document is current
Any future updates will be listed below
-
Authors
Olson, Daniel G.
Maloney, Marybeth I.
Lanahan, Anthony A.
Cervenka, Nicholas D.
Xia, Ying
Pech-Canul, Angel
Hon, Shuen
Tian, Liang
Ziegler, Samantha J.
Bomble, Yannick J.
Lynd, Lee R.
-
Funding
Funding for this research was provided by:
Center for Bioenergy Innovation (DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725, DE-AC05-00OR22725)
U.S. Department of Energy (DE-AC02–05CH11231)
Center for Biomedical Informatics and Information Technology, National Cancer Institute (5P30CA023108)
- License Information
-
More Information
Article History
Received: 7 July 2023
Accepted: 5 August 2023
First Online: 14 September 2023
Declarations
:
: Not applicable.
: All authors reviewed the manuscript and consented to its publication.
: Two authors are affiliated with the Terragia corporation (): Lee Lynd (co-founder) and Shuen Hon (employee). Terragia has a financial interest in commercialization of <i>Clostridium thermocellum</i>. There are no other competing interests.
